Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo M Horlings

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 24, 2016
Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the VulvaDeyin Xing, Salwa Bakhsh, Nataliya Melnyk, et al.
BMC Cancer|February 9, 2017
Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancerCong Lin, Christof J Majoor, Joris J T H Roelofs, et al.
BMC Genomics|August 8, 2008
Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stabilityMartin H van Vliet, Fabien Reyal, Hugo M Horlings, et al.
BMC Cancer|December 2, 2010
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutationsHenne Holstege, Hugo M Horlings, Arno Velds, et al.
BMC Bioinformatics|November 1, 2007
SIRAC: Supervised Identification of Regions of Aberration in aCGH datasetsCarmen Lai, Hugo M Horlings, Marc J van de Vijver, et al.
Genome Biology|January 9, 2014
Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasetsThalia A Farazi, Jelle J Ten Hoeve, Miguel Brown, et al.
NPJ Breast Cancer|September 15, 2022
Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situFaranak Sobhani, Sathya Muralidhar, Azam Hamidinekoo, et al.
Breast Cancer Research and Treatment|June 14, 2011
Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroupsAlexandra J van den Broek, Annegien Broeks, Hugo M Horlings, et al.
Cancer Treatment Reviews|November 8, 2020
Prognostic factors in patients with oligometastatic breast cancer - A systematic reviewAnnemiek van Ommen-Nijhof, Tessa G Steenbruggen, Winnie Schats, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancerPaul Roepman, Hugo M Horlings, Oscar Krijgsman, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 24, 2016
Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the VulvaDeyin Xing, Salwa Bakhsh, Nataliya Melnyk, et al.
BMC Cancer|February 9, 2017
Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancerCong Lin, Christof J Majoor, Joris J T H Roelofs, et al.
BMC Genomics|August 8, 2008
Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stabilityMartin H van Vliet, Fabien Reyal, Hugo M Horlings, et al.
BMC Cancer|December 2, 2010
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutationsHenne Holstege, Hugo M Horlings, Arno Velds, et al.
BMC Bioinformatics|November 1, 2007
SIRAC: Supervised Identification of Regions of Aberration in aCGH datasetsCarmen Lai, Hugo M Horlings, Marc J van de Vijver, et al.
Genome Biology|January 9, 2014
Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasetsThalia A Farazi, Jelle J Ten Hoeve, Miguel Brown, et al.
NPJ Breast Cancer|September 15, 2022
Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situFaranak Sobhani, Sathya Muralidhar, Azam Hamidinekoo, et al.
Breast Cancer Research and Treatment|June 14, 2011
Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroupsAlexandra J van den Broek, Annegien Broeks, Hugo M Horlings, et al.
Cancer Treatment Reviews|November 8, 2020
Prognostic factors in patients with oligometastatic breast cancer - A systematic reviewAnnemiek van Ommen-Nijhof, Tessa G Steenbruggen, Winnie Schats, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancerPaul Roepman, Hugo M Horlings, Oscar Krijgsman, et al.
Pageof 11